BGM Group Ltd. (BGM) vs Entera Bio Ltd. (ENTX)
A side-by-side comparison of BGM Group Ltd. and Entera Bio Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGM
BGM Group Ltd.
$8.76HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
ENTX
Entera Bio Ltd.
$2.59HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
Total return — BGM vs ENTX
growth of $100 · dividends reinvested · last 2yBGM -94.3% (-76.2%/yr)ENTX +69.0% (+30.0%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
BGM ENTX
BGM vs ENTX: by the numbers
- •ENTX is the larger company ($128M vs $111M market cap).
- •Both run net losses; BGM's is the smaller (-52.59% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | BGM | ENTX |
|---|---|---|
| P/B ratio | 0.28 | 17.57 |
Profitability
| Metric | BGM | ENTX |
|---|---|---|
| Gross margin | 12.79% | 0.00% |
| Operating margin | -33.18% | -27450.00% |
| Net margin | -52.59% | -27235.71% |
| ROE | -5.10% | -234.42% |
| ROIC | -3.19% | -82.87% |
Growth (annualized)
| Metric | BGM | ENTX |
|---|---|---|
| Revenue CAGR (5Y) | -5.39% | N/A |
| Total return CAGR (5Y) | N/A | -10.57% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.